Test your knowledge of the week in news, and take last week’s quiz here. Jeremy Mikula is the weekend director of platforms ...

Sonic the Hedgehog 3—starring James Marsden, Jim Carrey and the voices of Keanu Reeves, Idris Elba and Ben Schwartz—is coming soon to Paramount+. Sonic the Hedgehog, of course, is based on the ...

For years, social media users have shared what they describe as Netflix's original logo featuring black lettering and a ...

“Captain America: Brave New World” infused some blockbuster cash into the North American box office, bringing in $88.5 million in ticket sales over the weekend, according to studio estimates Sunda ...

Could they make one more blockbuster addition? This offseason the Dodgers have added Blake Snell, Rōki Sasaki, Hye-seong Kim, and Tanner Scott. They were rumored to be interested in Nolan Arenado ...

Kansas City Royals fans don't need to be told at this point that their team lacks a strong outfield. For a team with designs on competing for an American League pennant, a starting outfield of MJ ...

To their credit, the Kansas City Royals have tried to improve their outfield during this winter's hot stove period. It just hasn't worked out as of yet. Whether it was offering too little for ...

The Boston Red Sox have had a big week. Boston has kicked of Spring Training and has a new superstar in town in Alex Bregman. The former Houston Astros star signed a three-year, $120 million with ...

The blockbuster Pixar and Disney film Inside Out 2 also arrived on Disney’s streaming service more than three months after its theatrical release. Stay tuned to learn the exact Disney+ release date.

Pushpa 2, starring Allu Arjun in the lead role, was a pure carnage at the Indian box office. Out of all languages, the Hindi-dubbed version stole the maximum limelight due to its unprecedented run ...

A study finds that from 2000 through 2019, blockbuster movie releases — defined as releases in more than 4,000 theaters — boosted the stock market the following week by an average of half a ...

Eli Lilly's second candidate on the blockbuster list is a monoclonal antibody targeting the p19 subunit of IL-23, heading for a first-in-class approval in ulcerative colitis and third place for IL ...